A private equity firm accused of trying to build a monopoly in radiology was dismissed as a defendant in an ongoing lawsuit filed by the Federal Trade Commission against U.S. Anesthesia Partners in Texas.

Senator Bernie Sanders is upping the pressure on Novo Nordisk to lower the cost of Wegovy in the U.S., although the Danish drugmaker asserts it charges lower prices in Europe because governments there can negotiate prices.

Women earn less than men, often take time away from work for caregiving and live longer, which is why they say Congress needs to shore up Social Security and employers should contribute more to their plans, says a new survey.

Dogs accounted for 78.6% of insured pets in North America this past year, according to the North American Pet Health Insurance Association.

"These are multisided giants that are accumulating assets at an alarming rate and are becoming the new intermediaries and gatekeepers of our health care system," said Assistant U.S. Attorney General Jonathan Kanter.

The agency has stepped up its campaign against drugmakers' improper listing of patents in the FDA's Orange Book, which it contends are ploys intended to delay generic competition, by disputing junk patent listings for 300 drugs.

The BIOSECURE Act seeks to sever ties with some Chinese biotech players, however, these firms are heavily embedded in the U.S. pharmaceutical industry, which is already struggling with widespread drug shortages.

The investment firm is among 600 organizations worldwide whose pension funds and benefits plan providers had their participants' data breached recently, and should be "a wake-up call" to all plan sponsors, say industry experts.